Methotrexate in rheumatoid arthritis: an update.

Area of Science:

• Rheumatology
• Pharmacology

Background:

• Rheumatoid arthritis (RA) management often requires advanced therapies.
• Conventional treatments may be insufficient for some RA patients.

Purpose of the Study:

• To evaluate the efficacy and safety of methotrexate in RA.
• To explore methotrexate's potential for broader clinical application.

Main Methods:

• Systemic administration of methotrexate at 7.5-15 mg weekly.
• Pulse dosing regimen utilized.

Main Results:

• Methotrexate demonstrates effectiveness in controlling RA.
• Weekly pulse administration appears safe, with no serious adverse effects noted.
• High response rates observed in clinical studies.

Conclusions:

• Methotrexate is a viable option for refractory rheumatoid arthritis.
• Ease of administration and high efficacy suggest increased future use.
• Further controlled trials may support expanded indications.